切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2016, Vol. 10 ›› Issue (02) : 93 -98. doi: 10.3877/cma.j.issn.1674-0793.2016.02.002

所属专题: 文献

论著

黏着斑激酶表达下调对肝癌细胞黏附迁移侵袭行为的影响
阿力亚1, 胡文杰2, 彭宝岗2, 何强2,()   
  1. 1. 510080 广州,中山大学附属第一医院特需三科
    2. 510080 广州,中山大学附属第一医院肝胆外科
  • 收稿日期:2016-01-31 出版日期:2016-04-01
  • 通信作者: 何强
  • 基金资助:
    广东省教育厅自然科学研究计划项目(2009B030801175)

Effect of down-regulation of focal adhesion kinase on adhesion, migration and invasion of liver cancer cells

Aliya1, Wenjie Hu2, Baogang Peng2, Qiang He2,()   

  1. 1. Unit 3, Center for Private Medical Service and Health Care, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    2. Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2016-01-31 Published:2016-04-01
  • Corresponding author: Qiang He
  • About author:
    Corresponding author: He Qiang, Email:
引用本文:

阿力亚, 胡文杰, 彭宝岗, 何强. 黏着斑激酶表达下调对肝癌细胞黏附迁移侵袭行为的影响[J/OL]. 中华普通外科学文献(电子版), 2016, 10(02): 93-98.

Aliya, Wenjie Hu, Baogang Peng, Qiang He. Effect of down-regulation of focal adhesion kinase on adhesion, migration and invasion of liver cancer cells[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2016, 10(02): 93-98.

目的

研究下调黏着斑激酶(FAK)表达对人肝癌细胞HCC-LM3黏附迁移侵袭行为的影响及可能涉及的机制。

方法

根据处理方法不同,将人肝癌细胞HCC-LM3分为未处理组(肿瘤细胞未经处理)、对照组(肿瘤细胞转染空载体,FAK表达未改变)和FAK-shRNA组(肿瘤细胞稳定低表达FAK)。分别采用细胞黏附实验、划痕实验、Transwell实验检测3组肝癌细胞的黏附、迁移、侵袭能力,Western blotting检测细胞黏附侵袭相关蛋白paxillin、p130Cas以及基质金属蛋白酶MMP-2与MMP-9蛋白的表达及活化情况。

结果

FAK表达下调后,细胞黏附能力显著受到抑制,细胞迁移能力和侵袭能力均明显下降;细胞黏附分子p130Cas、paxillin的蛋白总量表达无明显改变,而磷酸化水平明显降低,其活化形式p-paxillin和p-p130Cas表达则明显受到抑制;MMP-2、MMP-9蛋白表达水平则在下调FAK表达后明显降低(P<0.01)。

结论

在人肝癌细胞HCC-LM3中,下调FAK表达可以影响肝癌细胞黏附迁移侵袭能力,其机制可能是通过调节相关细胞黏附分子的表达或活化来实现。

Objective

To study the effect and mechanism of down-regulation of focal adhesion on cell adhesion, migration and invasion of hepatocellular carcinoma cells.

Methods

According to the different treatments, human HCC-LM3 cells were divided into untreated group (tumor cells were not treated), control group (tumor cells were transfected with the empty vector) and FAK-shRNA group(expression of FAK was stably low). Cell adhesion, migration and invasion were tested by using cell adhesion assay, wound healing assay and Transwell assay, respectively. The expression and activation of cell adhesion and invasion related protein paxillin, p130Cas, matrix metalloproteinase (MMP)-2 and MMP-9 were detected by using Western blotting in HCC-LM3 cells (untreated group, control group and FAK-shRNA group).

Results

Down-regulation of FAK could significantly reduce the ability of cell adhesion, migration and invasion. The activation of paxillin and p130Cas were not influenced, while p-paxillin and p-p130Cas were inhibited, and the expression of MMP-2 and MMP-9 were significantly decreased (P<0.01).

Conclusion

Down-regulation of FAK can affect cell adhesion, migration and invasion by regulating the expression or activation of cell adhesion molecules in human HCC-LM3 cells.

图1 细胞黏附实验检测FAK表达下调对肿瘤细胞黏附能力的影响。n=3,与未处理组及对照组比较,P<0.01
图2 划痕实验结果检测FAK表达下调对肿瘤细胞迁移能力的影响,分别于不同时间段对比3组细胞修复划痕的程度
图3 Transwell迁移实验检测下调FAK表达对HCC-LM3细胞迁移能力的影响,将肿瘤细胞种至没有Matrigel的上室孵育24 h后,计数迁移至下室的细胞数(a)(结晶紫染色,×100)以及统计图(b)。 ± sn=5,与未处理组及对照组比较,P<0.01
图4 Transwell侵袭实验检测下调FAK表达对HCC-LM3细胞侵袭能力的影响,将肿瘤细胞种至铺有Matrigel的上室孵育36 h后,计数迁移至下室的细胞数(a)(结晶紫染色,×100)以及统计图(b)。 ± sn=5,与未处理组及对照组比较,P<0.01
图5 Western blotting法检测paxillin、p-paxillin、p130Cas、p-p130Cas、MMP-2、MMP-9蛋白表达
1
Lau WY,Lai EC. Hepatocellular carcinoma: current management and recent advances[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3): 237-257.
2
Avizienyte E,Evans J,Brunton VG, et al. The role of focal-adhe-sion kinase in cancer, a new therapeutic opportunity[J]. Nat-Rev Cancer, 2005, 5(7): 505-515.
3
Chen JS,Huang XH,Wang Q, et al. FAK is involved in invasion and metastasis of hepatocellular carcinoma[J]. Clin Exp Metasta-sis, 2010, 27(2): 71-82.
4
阿力亚,林武,何强. FAK-shRNA重组逆转录病毒载体的构建及稳定表达细胞株的筛选[J].中国病理生理杂志, 2011, 27(4): 688-694.
5
Schaller MD. FAK and paxillin: regulators of N-cadherin adhe-sion and inhibitors of cell migration? [J]. Cell Biol, 2004, 166(2): 157-159.
6
Zeng F,Luo F,Lv S, et al. A monoclonal antibody targeting neuro-pilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronec-tin by suppressing the FAK/p130cas signaling pathway[J]. Anti-cancer Drugs, 2014, 25(6): 663-672.
7
Chen YY,Liu FC,Chou PY, et al. Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung ade-nocarcinoma cells migration by inhibiting matrix metalloprotein-ase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling path-ways[J]. Evid Based Complement Alternat Med, 2012, 2012:378415.
8
Hegarty PK. MMP-2 and MMP-9 in lymph-node-positive blad-der cancer[J]. J Clin Pathol, 2012, 65(5): 470-471.
9
Zhao J,Guan JL. Signal transduction by focal adhesion kinase in cancer[J]. Cancer Metastasis Rev, 2009, 28(1-2): 35-49.
10
Megison ML,Stewart JE,Nabers HC, et al. FAK inhibition de-creases cell invasion, migration and metastasis in MYCN ampli-fied neuroblastoma[J]. Clin Exp Metastasis, 2013, 30(5): 555-568.
11
Kong X,Li G,Yuan Y, et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression[J]. PLoS One, 2012, 7(8): e41523.
12
Shang N,Arteaga M,Zaidi A, et al. FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis[J]. Hepatology, 2015, 61(1): 214-226.
13
陈连周,刘敏,欧阳文婷,等.黏着斑激酶在肝细胞肝癌中的表达及其与预后的关系[J].中国医药, 2010, 5(1): 9-10.
14
韩少山,刘青光,周振宇,等. FAK在肝癌组织中的表达及临床病理意义[J].西安交通大学学报, 2013, 34(1): 81-84, 127.
15
Golubovskaya VM,Sumbler B,Ho B, et al. MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells[J]. Anti-cancer Agents Med Chem, 2014, 14(1): 18-28.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[4] 梅杰, 徐瑞, 蔡芸, 朱一超. 纤维化对肿瘤浸润免疫细胞的影响——“硬冷肿瘤”的形成[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 257-263.
[5] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[6] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[7] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[8] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[9] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[10] 欧阳佳裕, 李刚, 贺露瑶, 罗娜. 双层探测器光谱CT在早期原发性肝癌中的诊断价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 557-561.
[11] 王凯飞, 牟怡平, 李晓辉, 王瑞涛, 侯惠莲, 张月浪. 原发性肝平滑肌肉瘤临床病理特征及疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 357-362.
[12] 陈志坚, 俞建达, 池小斌, 吕立志, 陈永标. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 302-307.
[13] 黄俊豪, 陈宗杰, 胡添松. 血小板相关参数对肝内胆管细胞癌根治性切除患者预后预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 308-312.
[14] 马欢欢, 马晨辉, 邓小博, 王博方, 何普毅, 王云鹏, 许博, 俞荣, 王娜, 陈昊. 肝癌实体瘤治疗疗效评价系统的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 377-383.
[15] 胡志恒, 任洪波, 宋志远, 张运刚, 韩晓正. 血清sTIM-3及其配体Gal-9、CEACAM-1与创伤性颅脑损伤患者脑损伤程度及预后的关系[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 201-207.
阅读次数
全文


摘要